High expression of A20 in tumor-infiltrating CD8+ T cells has been reported to be related to poor antitumor immune response, and the loss of A20 is associated with the increased ability of CD8+ T cells in tumor clearance. The gene discussed is CD8A; the disease is neoplasm.